DittertL. W.DeSantoA. R.: The Bioavailability of Drug Products, J. Amer. Pharm. Assoc.NS13: 421–432 (Aug.) 1973.
2.
SmithR. B.DittertL. W.GriffenW. O.Jr.DoluisioJ. T.: Pharmacokinetics of Pentobarbital After Intravenous and Oral Administration, J. Pharmacokinetics Biopharmaceutics1: 5–16, 1973.
3.
KojimaS.SmithR. B.DoluisioJ. T.: Drug Absorption V. Influence of Food on Oral Absorption of Phenobarbital in Rats, J. Pharm. Sci.60: 1639–1641, 1971.
4.
WagnerJ. G.: Biopharmaceutics: Absorption Aspects, J. Pharm. Sci.50: 359–387, 1961.
5.
SwintoskyJ. V.BlytheR. H.: The Excretion of Free Salicylate from an Enteric Coated Tablet and a Compressed Tablet, Drug Standards28: 5–8, 1960.
6.
JeliffeR. W.: A Mathematical Analysis of Digitalis Kinetics in Patients with Normal and Reduced Renal Function, Math. Bioscience1: 305–325, 1967.
7.
JeliffeR. W.: An Improved Method of Digoxin Therapy, Ann. Intern. Med.69: 703–717, 1968.
8.
DoluisioJ. T.DittertL. W.: Influence of Repetitive Dosing of Tetracyclines on Biologic Half-Life in Serum, Clin. Pharmacol. Ther.10: 690–701, 1969.
9.
OrmeB. M.CutlerR. E.: The Relationship between Kanamycin Pharmacokinetics: Distribution and Renal Failure, Clin. Pharmacol. Ther.10: 543–550, 1969.
10.
CutlerR. E.OrmeB. M.: Correlation of Serum Creatinine Concentration and Kanamycin Half-Life, J. Amer. Med. Assoc.209: 539–542, 1969.
